Tatsuki R Kataoka

Summary

Affiliation: Graduate School
Country: Japan

Publications

  1. pmc An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto 606 8507, Japan
    World J Surg Oncol 12:186. 2014
  2. ncbi request reprint PD-1 regulates the growth of human mastocytosis cells
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Allergol Int 62:99-104. 2013
  3. pmc CD72 negatively regulates KIT-mediated responses in human mast cells
    Tatsuki R Kataoka
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 184:2468-75. 2010
  4. pmc CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Sci Rep 3:2861. 2013

Detail Information

Publications4

  1. pmc An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto 606 8507, Japan
    World J Surg Oncol 12:186. 2014
    ..Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive. ..
  2. ncbi request reprint PD-1 regulates the growth of human mastocytosis cells
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Allergol Int 62:99-104. 2013
    ..Programmed death-1 (PD-1) is a marker for human neoplastic T cells. Here, we evaluated whether or not PD-1 was also a marker for human mastocytosis, and explored the role of PD-1 in human mastocytosis cells...
  3. pmc CD72 negatively regulates KIT-mediated responses in human mast cells
    Tatsuki R Kataoka
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 184:2468-75. 2010
    ..Furthermore, BU40 and rCD100 also downregulated the growth of the HMC1.2 human mast cell line. Thus, targeting CD72 may provide a novel approach to the suppression of mast cell disease such as mastocytosis...
  4. pmc CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Sci Rep 3:2861. 2013
    ..Thus, these results seemed to suggest that CD72 was the therapeutic potential for AML, as is the case of MCTs. ..